ABBV — AbbVie Inc. | ScreenerHero

Create free account Sign in

ABBVAbbVie Inc.

VIE · AT · Healthcare · Drug Manufacturers - General

178.65EURMkt Cap: 311.40B EURP/E: 101.88Last update: 2026-05-12

Industry Peers

Drug Manufacturers - General

AstraZeneca PLC

2.60TSEKP/E 27.3

Novo Nordisk A/S

1.26TDKKP/E 10.4

Eli Lilly and Company

964.74BUSDP/E 38.4

Johnson & Johnson

537.98BUSDP/E 25.9

Merck & Co., Inc.

285.26BUSDP/E 32.5

Roche Holding AG

257.94BCHFP/E 20.2

222.33BCHFP/E 20.3

217.33BCHFP/E 20.7

Indicators:|

Key Statistics

Company

Market Cap311.40B EUR

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)—

Revenue/Share—

Last Price178.65 EUR

Fiscal Year End—

MR Quarter—

Employees—

CountryAT

SectorHealthcare

IndustryDrug Manufacturers - General

ISINUS00287Y1091

Valuation

P/E (Trailing)101.88

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B—

EPS (TTM)—

EPS (Forward)—

52W Range

176.25100% of range177.40

52W High177.40 EUR

52W Low176.25 EUR

Profitability

Gross Margin—

Oper. Margin—

EBITDA Margin—

Profit Margin—

ROE—

ROA—

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF—

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio—

Quick Ratio—

Book Value/Sh—

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate—

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float—

Insiders—

Institutions—

Technical

SMA 50—

SMA 200—

Beta—

S&P 52W Chg—

Avg Vol (30d)0

Avg Vol (10d)—

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—